Solid phase synthesis of 1-aminohydantoin libraries

Tetrahedron Letters

Volumn 39, Issue 29, 1998, Pages 5135-5138

  Wilson, Lawrence J ^a   Li, Min ^a   Portlock, David E ^a  

^a PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINOHYDANTOIN; ALDEHYDE; AMINE; ANTIARRHYTHMIC AGENT; ANTIINFECTIVE AGENT; AZIMILIDE; DANTROLENE; DRUG CARRIER; NITROFURANTOIN; UNCLASSIFIED DRUG;

ANTIARRHYTHMIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG PURIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION;

EID: 0032537666     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(98)01009-0     Document Type: Article

References (22)

1. 1. (a) The thematic combinatorial issue of Chemical Reviews: Chem. Rev. 1997, 97(2);
2. (b) Section 1 in Annual Reports in Combinatorial Chemsitry and Molecular Diversity Vol. 1, ESCOM Pub., 1997, Ed. W.H. Moos, M.R. Pavia, B.K. Kay, A.D. Ellington;
3. (c) Hermkens, P.H.H.; Ottenheijm, H.C.J.; Rees, D. Tetrahedron 1996, 52(13), 4527-4554.
4. 2. (a) Davis, C.S.; Snyder, H.R. US Pat 3,415,821;
5. (b) Yu, C.-N.; Pelosi, S.S.; Calcagno, M.A. US Pat 5,462,940;
6. (c) Barraclough, P.; Bolofo, M.L.; Giles, H.; Gillam, J.; Harris, C.J.; Kelly, M.G.; Leff, P.; McNeill, A.; Robertson, A.D.; Stepney, R.J.; Whittle, B.J.R. Biorg. Med. Chem. 1996 (4), 81-90.
7. 3. (a) General reference: Kline, T.; Mueller, L.; Sieber-McMaster, E.; Lau, W.F.; Meyers, C.A. Int. J. Peptide Protein Res. 1996, 47, 142-147;
8. (b) Anti-tumor, antibiotics: Azinothricin-Citropeptin: Hale, K.J.; Delisser, V.M.; Manaviazar Tetrahedron Lett. 1992, 33, 7613-7616;
9. (c) MMP inhibitors: Cherney, R.J.; Decicco, C.P.; Nelson, D.J.; Wang, L.; Meyer, D.T.; Hardman, K.D.; Copeland, R.A.; Arner, E.C. Biorg. Med. Chem. Lett. 1997, 7, 1757-1762;
10. (d) Semicarbazone as a peptidomimetic group: Limal, D.; Grand, V.; Vanderesse, R.; Marraud, M. Tetrahedron Lett. 1994, 35, 3711-3714.
11. 4. There are currently five solid phase based hydantoin routes that utilize cyclizative cleavage: (a) Dewitt, S.H.; Kiely, J.S.; Stankovic, C.J.; Schroeder, M.C.; Reynolds Cody, D.M.; Pavia, M.R. Proc. Natl. Acad. Sci. 1993, 90, 6909-6913;
12. (b) Dressman, B.A.; Spangle, L.A.; Kaldor, S.W. Tetrahedron Lett. 1996, 37, 937-940;
13. (c) Hanessian, S.; Yang, R.-Y. Tetrahedron Lett. 1996, 37, 5835-5838;
14. (d) Kim, S.W.; Ahn, S.Y.; Koh, J.S.; Lee, J.H.; Ro, S.; Cho, H.Y. Tetrahedron Lett. 1997, 38, 4603-4606;
15. (e) Matthews, J.; Rivero, R.A. J. Org. Chem. 1997, 62, 6090-6092.
16. 5. Amine displacements on alpha-bromo resin esters: Scott, B.O.; Siegmund, A.C.; Marlowe, C.K.; Pei, Y.; Spear, K.L. Molecular Diversity 1995, 1, 125-134.
17. 1=Me, Et, i-Bu, i-Pr, Bn) using the method according to Hoffman, R.V.; Kim, H.-O. Tetrahedron Lett. 1990, 31, 2953-2956. This gives the option of introducing chirality at the alpha carbon, however racemic starting materials were utilized in each case.
18. 7. Spatola, A.F.; Darlak, K.; Romanvskis, P. Tetrahedron Lett. 1996, 37, 591-594.
19. 8. Hutchins, S.M.; Chapman, K.T. Tetrahedron Lett. 1994, 35, 4055-4058.
20. 9. Davies, J.S.; Merritt, R.K.; Treadgold, R.C. J. Chem. Soc. Perkin Trans. I 1982, 2939-2947.
21. 2: C, 50.6; H, 4.98; N, 18.38. Found: C, 50.1; H, 4.73; N, 17.9.
22. 11. For entry 13, phenyl alanine was utilized as the silylated (TMS) ester by first heating the acid in bis(trimethylsilyl)acetamide (BSA, 3 equiv., DMF, 80°C), followed by cooling to room temperature, and then addition of the solution directly to the resin (step h, Scheme 1). Also, DMAP was used in place of DIPEA.